Systemic ascorbate depletion promotes the development of Tet2+/− or Tet2−/− myeloid neoplasms, suggesting TET2-dependent and TET2-independent effects (Agathocleous et al., 2017; Guan et al., 2020). The gene discussed is TET2; the disease is myeloid neoplasm.